3,618
Views
5
CrossRef citations to date
0
Altmetric
Oncology

Tumour budding is a novel marker in breast cancer: the clinical application and future prospects

, , , , , & show all
Pages 1303-1312 | Received 23 Feb 2022, Accepted 20 Apr 2022, Published online: 10 May 2022

Reprints and Permissions

This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.

You are not required to obtain permission to reuse this article in part or whole.